Hot Papers

W.W. Lamph, P. Wamsley, P. Sassone-Corsi, I.M. Verma, "Induction of proto-oncogene JUN/AP-1 by serum and TPA," Nature, 334 (6183), 629-31, 18 August 1988. William W. Lamph (Molecular Biology and Virology Laboratory, Salk Institute, La Jolla, Calif.): "This paper demonstrates that routine proto-oncogene jun is inducible in NIH 3T3 cells with serum or TPA and, hence, like proto-oncogene fos, belongs to the immediate early family of genes. The coordinate expression of these genes, fos and jun, is

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"Therefore, this paper provides a link between incoming signals from extracellular stimuli and the activation of a network of genes (including fos and jun) whose gene products are able to transactivate secondary genes in response to the stimulus."

"The article considers, among other matters, the findings that many eukaryotic regulatory proteins work when bound to sites a great distance removed from the controlled gene; that at least one class of activators discovered in yeast will activate genes in many-perhaps all-eukaryotes; and that very often different regulators work together (cooperatively) to control gene expression.

"The ideas discussed describe these phenomena in terms of (or in contrast with) the workings of the lambda phage repressor, the case for which we have our most detailed molecular understanding. It will be interesting to see in what ways the picture offered is an oversimplification."

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies